Review
Copyright ©The Author(s) 2016.
World J Hematol. Feb 6, 2016; 5(1): 1-22
Published online Feb 6, 2016. doi: 10.5315/wjh.v5.i1.1
Table 3 Published mouse models of myelodysplastic syndromes
Gene(s) studiedModel/techniqueTractability to human MDS
Ref.
AnemiaMulti-lineage cytopeniasDysplasiaBone marrow cellularityHSPC skewingSecondary leukemiaLatency to leukemiaSurvival
NUP98-HOXD13TransgenicYesYesYesHyper-YesYes214 mo-[69]
Cd74-Nid67Large scale chromosomal deletion, RPS14 haploinsufficientYesNoYesHypo-YesNo-1[92]
SPARCKnock-outNoNoYes11No-1[97]
MIR-145, MIR146aRetroviral transductionNoNoYes11Yes4-14 mo-[143]
APCTransgenic, haploinsufficientYesNoYes1YesNo-3-8 mo[99]
Csnk1a1Transgenic, inducibleYesYesYesYesYesNo-1[94]
Srsf2Transgenic, inducibleYesYesYesNormalYesNo-1[98]
U2af1Transgenic, inducibleNoNoNoNormalYesNo--[100]
Sf3b1Transgenic, haploinsufficientYesNoYes11No-About 12 mo[101]
RUNX1-D171NRetroviral transductionYesYesYesNormal to hyper-1Yes4-13 mo-[105]
RUNX1-S291fsX300Retroviral transductionYesYesYesNormal to hyper-1Yes4-13 mo-[105]
RUNX1S291fs/Ezh2Retroviral transductionYesYesYesVariable1No-262 d[125]
Tet2Transgenic, hypomorphicYesYesYesHyper-YesNo-11 mo[115]
Tet2/Ezh2Transgenic, inducibleYesYesYesHyper-YesNo-10 mo[141]
ASXL1Transgenic, inducibleYesYesYesHypo-YesNo-Median 50 wk[122]
Asxl1Transgenic, constitutiveYesYesYesNormal to hyper-Yes316 mo8-42 d-[123]
TERTTransgenic, inducibleYesYesYesHyperYesYes112 mo[124]
Evi1Retroviral transductionYesYesYesHyper-1No-10-12 mo[136]
SALL4TransgenicYesYesYesHyper-YesYes6 wk to 12 mo-[139]
Npm1Transgenic, haploinsufficientNoNoYesHyperNoYes24 mo-[138]
NRASD12-BCL2Transgenic, inducible/constitutive1NoYes1YesYes3-6 mo-[142]
Pten/ShipTransgenic, Pten +/- Ship -/-YesYes1HypoYesNo-5 wk[140]
DidoKnock-outYesNoYes11No-1[137]
Arid4aKnock-outYesYesYesHyper-1Yes5 mo-[144]
Mll5Knock-outYesNoNo11No--[145]